AAAAAA

   
Results: 1-12 |
Results: 12

Authors: GARBESI A HAMY F MAFFINI M ALBRECHT G KLIMKAIT T
Citation: A. Garbesi et al., TAR-RNA BINDING BY HIV-1 TAT PROTEIN IS SELECTIVELY INHIBITED BY ITS L-ENANTIOMER, Nucleic acids research, 26(12), 1998, pp. 2886-2890

Authors: KLIMKAIT T STAUFFER F LUPO E SONDEREGGERRUBLI C
Citation: T. Klimkait et al., DISSECTING THE MODE OF ACTION OF VARIOUS HIV-INHIBITOR CLASSES IN A STABLE CELLULAR-SYSTEM, Archives of virology, 143(11), 1998, pp. 2109-2131

Authors: BOLD G FASSLER A CAPRARO HG COZENS R KLIMKAIT T LAZDINS J MESTAN J PONCIONI B ROSEL J STOVER D TINTELNOTBLOMLEY M ACEMOGLU F BECK W BOSS E ESCHBACH M HURLIMANN T MASSO E ROUSSEL S UCCISTOLL K WYSS D LANG R
Citation: G. Bold et al., NEW AZA-DIPEPTIDE ANALOGS AS POTENT AND ORALLY ABSORBED HIV-1 PROTEASE INHIBITORS - CANDIDATES FOR CLINICAL DEVELOPMENT, Journal of medicinal chemistry, 41(18), 1998, pp. 3387-3401

Authors: HAMY F BRONDANI V FLORSHEIMER A STARK W BLOMMERS MJJ KLIMKAIT T
Citation: F. Hamy et al., A NEW CLASS OF HIV-1 TAT ANTAGONIST ACTING THROUGH TAT-TAR INHIBITION, Biochemistry, 37(15), 1998, pp. 5086-5095

Authors: HAMY F FELDER ER HEIZMANN G LAZDINS J ABOULELA F VARANI G KARN J KLIMKAIT T
Citation: F. Hamy et al., AN INHIBITOR OF THE TAT TAR RNA INTERACTION THAT EFFECTIVELY SUPPRESSES HIV-1 REPLICATION/, Proceedings of the National Academy of Sciences of the United Statesof America, 94(8), 1997, pp. 3548-3553

Authors: LAZDINS JK MESTAN J GOUTTE G WALKER MR BOLD G CAPRARO HG KLIMKAIT T
Citation: Jk. Lazdins et al., IN-VITRO EFFECT OF ALPHA(1)-ACID GLYCOPROTEIN ON THE ANTI-HUMAN-IMMUNODEFICIENCY-VIRUS (HIV) ACTIVITY OF THE PROTEASE INHIBITOR CGP-61755 -A COMPARATIVE-STUDY WITH OTHER RELEVANT HIV PROTEASE INHIBITORS, The Journal of infectious diseases, 175(5), 1997, pp. 1063-1070

Authors: FACKLER OT KIENZLE N KREMMER E BOESE A SCHRAMM B KLIMKAIT T KUCHERER C MUELLERLANTZSCH N
Citation: Ot. Fackler et al., ASSOCIATION OF HUMAN-IMMUNODEFICIENCY-VIRUS NEF PROTEIN WITH ACTIN ISMYRISTOYLATION DEPENDENT AND INFLUENCES ITS SUBCELLULAR-LOCALIZATION, European journal of biochemistry, 247(3), 1997, pp. 843-851

Authors: CAPRARO HG BOLD G FASSLER A COZENS R KLIMKAIT T LAZDINS J PONCIONI B ROSEL JL STOVER D LANG M
Citation: Hg. Capraro et al., SYNTHESIS OF POTENT AND ORALLY-ACTIVE HIV-PROTEASE INHIBITORS, Archiv der pharmazie, 329(6), 1996, pp. 273-278

Authors: LAZDINS JK BOLD G CAPRARO HG COZENS R FASSLER A FLESCH G KLIMKAIT T LANG M MESTAN J PONCIONI B ROSEL J STOVER D TINTELNOTBLOMLEY M WALKER MR WOODSCOOK K
Citation: Jk. Lazdins et al., PROFILE OF CGP-61755 - A NOVEL AND POTENT HIV-1 PROTEASE INHIBITOR THAT SHOWS ENHANCED ANTI-HIV ACTIVITY WHEN COMBINED WITH OTHER ANTIRETROVIRAL AGENTS IN-VITRO, Schweizerische medizinische Wochenschrift, 126(43), 1996, pp. 1849-1851

Authors: KLIMKAIT T
Citation: T. Klimkait, STILL NO SILENCE, Nature, 372(6508), 1994, pp. 720-720

Authors: WYATT JR VICKERS TA ROBERSON JL BUCKHEIT RW KLIMKAIT T DEBAETS E DAVIS PW RAYNER B IMBACH JL ECKER DJ
Citation: Jr. Wyatt et al., COMBINATORIALLY SELECTED GUANOSINE-QUARTET STRUCTURE IS A POTENT INHIBITOR OF HUMAN-IMMUNODEFICIENCY-VIRUS ENVELOPE-MEDIATED CELL-FUSION, Proceedings of the National Academy of Sciences of the United Statesof America, 91(4), 1994, pp. 1356-1360

Authors: ALTERI E BOLD G COZENS R FAESSLER A KLIMKAIT T LANG M LAZDINS J PONCIONI B ROESEL JL SCHNEIDER P WALKER M WOODSCOOK K
Citation: E. Alteri et al., CGP-53437, AN ORALLY BIOAVAILABLE INHIBITOR OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 PROTEASE WITH POTENT ANTIVIRAL ACTIVITY, Antimicrobial agents and chemotherapy, 37(10), 1993, pp. 2087-2092
Risultati: 1-12 |